Nanchang, August 8 (Reporter Wu Pengquan) "The Jiangxi Provincial Party Committee and the provincial government will list free HPV vaccine for school-age girls as one of the 8 livelihood facts in Jiangxi Province in 2023, and provide free vaccination of domestic bivalent HPV vaccine for eligible junior high school age girls in the province, marking that the prevention and treatment of cervical cancer in Jiangxi has moved from the secondary prevention of 'accurate screening' to the primary prevention of 'precision prevention'." ”
At the Jiangxi Province Accelerated Elimination of Cervical Cancer Action and the Practical Press Conference on HPV Vaccination for School-age Girls held on the 8th, Zhu Liebin, member of the Party Group and deputy director of the Jiangxi Provincial Health Commission, said.
Cervical cancer is a major disease that seriously endangers women's health. Jiangxi has always attached great importance to the prevention and treatment of cervical cancer, actively responded to the national action plan to accelerate the elimination of cervical cancer, and included "free vaccination of human papillomavirus (HPV) vaccine for school-age girls" into the 2023 people's livelihood facts.
As the leading department of this livelihood matter, the Jiangxi Provincial Health Commission, with the support and cooperation of finance, education, women's federations and other departments, fully launched HPV vaccination on August 8, one month earlier than the original launch time. Jiangxi became the fifth province in the country to achieve free HPV vaccination for school-age girls.
Zhu Liebin said that Jiangxi has completed the centralized procurement of vaccines ahead of schedule, and the winning vaccine product is the bivalent human papillomavirus vaccine produced by Yuxi Zerun Biotechnology Co., Ltd. At present, procurement contracts have been signed with the winning enterprises in various parts of the province, and the vaccine distribution is all in place.
According to Deng Zhong, member of the party group and deputy director of the Jiangxi Provincial Department of Finance, in order to accelerate the practical implementation of people's livelihood, according to the relevant provisions of the Government Procurement Law and the application of the Jiangxi Provincial Health Commission, the Jiangxi Provincial Department of Finance has organized the centralized procurement of vaccines in the province in a fast and convenient way, effectively shortening the procurement time and greatly reducing the procurement cost, and has centralized procurement of 164.8 million doses of vaccines.
Jiangxi has also carried out a survey of HPV vaccination intentions, and a total of 39,1 school-age girls in the province have participated in the vaccination willingness survey, and 94.2% of girls are willing to be vaccinated.
The "Jiangxi Province Action Plan for Accelerating the Elimination of Cervical Cancer (2023-2030) Work Plan" jointly issued by multiple departments in Jiangxi recently proposed that in 2023, free HPV vaccination for girls of appropriate age will be carried out throughout the province. By 2025, the screening rate of cervical cancer among women of appropriate age in the province will reach 50%, and the treatment rate of patients with cervical cancer and precancerous lesions will reach 90%. By 2030, the HPV vaccination rate of school-age girls in the province will reach 90%, the cervical cancer screening rate of women of appropriate age will reach 70%, and the treatment rate of cervical cancer and precancerous lesions will reach 90%.
Zhu Liebin said that Jiangxi will strengthen the capacity building of cervical cancer prevention and control and improve the service capacity of medical institutions at all levels in the province; Promote the information management of cervical cancer prevention and treatment, and promote the interconnection and sharing of information and data; Promote the participation of new technologies in the prevention and treatment of cervical cancer, and explore the use of the Internet and artificial intelligence to optimize the screening and diagnosis and treatment service process. (End)